Scientists closer to drug that cuts nicotine dependence

 
Related

Eye-catching NuBike goes with drive levers instead of a chain

Health at home
586 points

How to tell if cheat days are sabotaging your weight loss

Health at home
274 points



Most recent

Cómo bajar el colesterol sin medicamentos con este simple consejo revelado por Harvard

NOTICIAS-ETF
188 points

Una noche en casa ajena, grupo ajeno, tertulia ajena

El diario de Enrique
6 points

La EMA aprueba la pastilla anticovid-19 de Merck para uso de emergencia

NOTICIAS-ETF
140 points

5 consejos para averiguar los gustos de alguien antes de hacerle un regalo

MaríaGeek
12 points

La OMS alerta q podrían producirse 700.000 muertes en Europa de aquí a marzo a causa del coronavirus

NOTICIAS-ETF
50 points

LA DEMOCRACIA EN PELIGRO

pensamiento Libre
60 points

CARTA A LOS SRES. VETERANOS DE LA GUERRA EN COLOMBIA

pensamiento Libre
68 points

Decidí seguir siendo feliz

El diario de Enrique
8 points

Cambio climático: guía simple para entender el calentamiento global

NOTICIAS-ETF
82 points

ELECTRICIDAD BARATA Y CERO CO2: Bill Gates arranca asalto las eléctricas con reactor nuclear barato

NOTICIAS-ETF
108 points
SHARE
TWEET
Researchers say they've created an enzyme that might one day reduce nicotine cravings in smokers.

Scientists closer to drug that cuts nicotine dependence

The scientists gave the enzyme to nicotine-dependent rats and found it broke down nicotine in the bloodstream before it could reach the brain.

This quickly reduced the rats' nicotine dependence. It also prevented them from relapsing when they again had access to nicotine, according to the study.

"This is a very exciting approach because it can reduce nicotine dependence without inducing cravings and other severe withdrawal symptoms," said principal investigator Olivier George. He's an associate professor at Scripps Research Institute in La Jolla, California.

U.S. FDA cracks down on electronic cigarette producers

The U.S. Food and Drug Administration sent letters to 21 electronic cigarette manufacturers seeking information to assess whether the products are being marketed illegally.

Also, the enzyme "works in the bloodstream, not the brain, so its side-effects should be minimal," George added in an institute news release.

Nicotine dependence is what makes it so difficult for people to quit smoking. Preventing the nicotine in tobacco from reaching the brain has long been seen as a promising way of reducing dependence, but previous efforts haven't resulted in drugs that reduce blood levels of nicotine enough to be effective.

The enzyme tested in this study is called NicA2-J1. It's based on a natural enzyme produced by the bacterium Pseudomonas putida, but was modified to boost its potency, staying time in the blood, and other features to fight nicotine dependence.

The researchers plan to continue to improve the enzyme's properties with the goal of eventually conducting human clinical trials. However, it's important to note that results of animal trials aren't always replicable in humans.

The findings were published online Octber 17 in Science Advances.

Fuente: www.health24.com
SHARE
TWEET
To comment you must log in with your account or sign up!
Featured content